SecBot SecBot

SIGA

SIGA TECHNOLOGIES INC
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001010086 Biotech & Drug Discovery
$2.85 +0.11 (+4.01%)
Nov 16 4:00 PM ET · prev $2.74
Market cap
$207.7M
Micro cap
1 year
−51.7%
from $5.90 · Nov 17
30 days
−9.2%
from $3.14
52-week range
$2.74–6.95
−59% from high · low Nov 13
Avg volume 20D
538.4K
shares / day
Short interest
3.57M
≈5.0% of shares · +0.1%
Days to cover
7.8
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 0 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q3 2026: 28 added (0 new), 12 trimmed or exited.

  • Short sellersSTEADY

    Short interest +0.1% to 3.57M shares. 7.8 days to cover, ≈5.0% of shares.

  • TrendDOWNTREND

    10% below its 50-day average. New closing low $2.74 on Nov 13.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.ADD5,469,195$18.6M
DIMENSIONAL FUND ADVISORS LPTRIM2,011,607$6.8M
MORGAN STANLEYDOUBLED1,270,042$4.3M
Qube Research & Technologies LtdADD1,164,207$4.0M
RENAISSANCE TECHNOLOGIES LLCADD637,236$2.2M
VANGUARD PORTFOLIO MANAGEMENT LLCTRIM407,605$1.4M
Nuveen, LLCDOUBLED237,757$808.4K
Squarepoint Ops LLCDOUBLED191,418$650.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Nov 2012
Recent actions
DateFirmActionRating
Nov 6, 2012Wedbush
MAINTAIN
MAINTAINOutperform

Washington

Corporate Lobbying

18 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 9, 2026
Marshall Joseph W III
Director
Jun 9, 2026
TO ISSUER$31.8K
Jun 9, 2026
Marshall Joseph W III
Director
Jun 9, 2026
AWARD34,169 sh
Jun 9, 2026
Nabel Gary J.
Director
Jun 9, 2026
EXERCISE24,116 sh
Jun 9, 2026
Nabel Gary J.
Director
Jun 9, 2026
TO ISSUER$31.8K
Jun 9, 2026
Nabel Gary J.
Director
Jun 9, 2026
AWARD34,169 sh
Jun 9, 2026
DURNAN JAYMIE A
Director
Jun 9, 2026
EXERCISE24,116 sh
Jun 9, 2026
DURNAN JAYMIE A
Director
Jun 9, 2026
TO ISSUER$31.8K
Jun 9, 2026
DURNAN JAYMIE A
Director
Jun 9, 2026
AWARD34,169 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FY$0.02$0.02–$0.02-60.0%$53.6M
Next FY$1.06$1.06–$1.06-1.9%$157.9M

Short side

FINRA· Oct 30, 2026
3,567,607
shares short
+0.1%
vs prior settlement
7.8
days to cover
≈5.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 9, 2026 SEC
SIGA reported Q3 2026 revenue of $1.3M, down 50% YoY from $2.6M, and a net loss of $2.9M ($0.04 per share) vs. a $6.4M…
PRESS-RELEASE · Impact 5/10
Nov 9, 2026 Earnings
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commerc
Nov 4, 2026 SEC
Three small asset managers added to SIGA positions in Q3 2026, while Dimensional Fund Advisors trimmed 26% of its…
INST-CLUSTER · Impact 3/10
Oct 28, 2026 Press
SIGA Technologies announced a new contract from the Canadian Department of National Defence for oral TPOXX…
Impact 3/10
Sep 30, 2026 Inst.
BlackRock, Inc. · ADD
5,469,195 shares ($18.6M)
Sep 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP · TRIM
2,011,607 shares ($6.8M)
Jun 9, 2026 Insider
Marshall Joseph W III disposed of 7,235 shares
Director @ $4.39 ($31.8K)
Jun 9, 2026 Insider
Marshall Joseph W III was granted 34,169 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent
Nov 9, 2026
Earnings
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026
NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported…
Nov 9, 2026
Press release
SIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.
Concludes 30-Year Tenure Leading Development of TPOXX®, the First FDA-Approved Antiviral for the Treatment of Smallpox Concludes 30-Year Tenure…
Nov 9, 2026
Earnings result
SIGA Q3 2026 Earnings: EPS $-0.04
Nov 2, 2026
Lobbying
SIGA TECHNOLOGIES, INC. (SIGA) lobbying spend hits a record: $240K in Q3 2026
+9% vs prior quarter, +9% vs a year earlier. 2 firms
Nov 2, 2026
Lobbying
SIGA TECHNOLOGIES, INC. (SIGA) hires lobbying firm HEALTH POLICY SOURCE, INC.
First report posted 2026-11-02

SecBot reports

4 filings · 2 press releases · 0 bullish · 2 bearish · 1 mixed · 1 neutral
All SIGA filing & press-release reports (6)